| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.36T | 4.51T | 3.97T | 2.30T | 1.37T | 1.41T |
| Gross Profit | 1.76T | 1.66T | 1.38T | 1.14T | 1.14T | 1.20T |
| EBITDA | 532.95B | 533.62B | 335.19B | 210.90B | 286.15B | 294.52B |
| Net Income | 370.05B | 340.74B | 165.86B | 92.79B | 143.00B | 153.12B |
Balance Sheet | ||||||
| Total Assets | 60.37T | 56.80T | 55.15T | 47.77T | 43.41T | 42.52T |
| Cash, Cash Equivalents and Short-Term Investments | 34.65T | 5.51T | 5.15T | 4.52T | 3.64T | 4.16T |
| Total Debt | 31.79T | 31.35T | 30.96T | 26.15T | 23.48T | 23.30T |
| Total Liabilities | 56.76T | 53.22T | 51.70T | 44.55T | 40.44T | 39.76T |
| Stockholders Equity | 3.49T | 3.47T | 3.35T | 3.15T | 2.91T | 2.69T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -868.58B | -13.14B | -865.99B | -974.16B | 545.89B |
| Operating Cash Flow | 0.00 | -678.61B | 132.64B | -694.82B | -862.83B | 665.77B |
| Investing Cash Flow | 0.00 | -848.65B | -887.94B | -233.22B | -593.18B | -139.03B |
| Financing Cash Flow | 0.00 | 1.68T | 1.01T | 1.28T | 1.11T | -269.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $164.67B | 20.00 | 17.91% | 1.07% | 5.90% | 66.60% | |
70 Outperform | $28.26B | 14.06 | 16.94% | 1.26% | 6.45% | 5.85% | |
69 Neutral | $263.85B | 16.54 | 15.45% | 2.14% | 7.22% | 48.18% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $23.19B | 10.54 | 10.23% | 4.76% | -1.61% | 37.04% | |
64 Neutral | $255.27B | 16.00 | 13.81% | 1.55% | 2.31% | 44.49% | |
60 Neutral | $23.16B | 32.56 | 18.57% | 0.32% | 35.19% | -18.62% |